Vemurafenib in patients with BRAFV600 mutation-positive metastatic melanoma: final overall survival results of the randomized BRIM-3 study.
Ann Oncol
; 28(10): 2581-2587, 2017 Oct 01.
Article
in En
| MEDLINE
| ID: mdl-28961848
Full text:
1
Database:
MEDLINE
Main subject:
Skin Neoplasms
/
Sulfonamides
/
Proto-Oncogene Proteins B-raf
/
Indoles
/
Melanoma
/
Mutation
Type of study:
Clinical_trials
Limits:
Adolescent
/
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Year:
2017
Type:
Article